Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Dermatologic Therapy
|
June 19, 2021
Therapeutic approaches and targets for treatment of autoimmune bullous diseases
Federico Bardazzi, Camilla Loi, Adriano Chessa Marco, et al.
Medicina (Kaunas, Lithuania)
|
November 27, 2024
Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
Michela Starace, Stephano Cedirian, Federico Quadrelli, et al.
European Journal of Dermatology : EJD
|
May 8, 2023
The potential role of serum polyclonal free light chains as markers of immune activation in psoriatic patients
Roberta Di Caprio, Lidia Sacchelli, Gaetano Di Spigna, et al.
Dermatology Practical & Conceptual
|
May 26, 2026
The Role of Anti-BP180 Antibody Monitoring in Bullous Pemphigoid: An Italian Single-Center Experience
Alice Massi, Stephano Cedirian, Giacomo Clarizio, et al.
European Journal of Dermatology : EJD
|
April 9, 2020
Outcome following a short period of adalimumab dose escalation as rescue therapy in psoriatic patients
Federico Bardazzi, Laura Bigi, Anna Campanati, et al.
Expert Opinion on Biological Therapy
|
January 19, 2022
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study
Marco Galluzzo, Marina Talamonti, Laura Atzori, et al.
Italian Journal of Dermatology and Venereology
|
July 25, 2025
Ethical and professional use of Social Media: Consensus of Italian Dermatologists active on social media
Lidia Sacchelli, Marta Fusano, Laura Colli, et al.
Expert Opinion on Biological Therapy
|
July 19, 2021
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy
Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini, et al.
Psoriasis (Auckland, N.Z.)
|
August 12, 2025
Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 years
Luca Mastorino, Paolo Dapavo, Martina Burlando, et al.
American Journal of Clinical Dermatology
|
April 15, 2025
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study
Ulrich Mrowietz, Crispin Meyer, Katja Großschädl, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Dermatologic Therapy
|
June 19, 2021
Therapeutic approaches and targets for treatment of autoimmune bullous diseases
Federico Bardazzi, Camilla Loi, Adriano Chessa Marco, et al.
Medicina (Kaunas, Lithuania)
|
November 27, 2024
Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
Michela Starace, Stephano Cedirian, Federico Quadrelli, et al.
European Journal of Dermatology : EJD
|
May 8, 2023
The potential role of serum polyclonal free light chains as markers of immune activation in psoriatic patients
Roberta Di Caprio, Lidia Sacchelli, Gaetano Di Spigna, et al.
Dermatology Practical & Conceptual
|
May 26, 2026
The Role of Anti-BP180 Antibody Monitoring in Bullous Pemphigoid: An Italian Single-Center Experience
Alice Massi, Stephano Cedirian, Giacomo Clarizio, et al.
European Journal of Dermatology : EJD
|
April 9, 2020
Outcome following a short period of adalimumab dose escalation as rescue therapy in psoriatic patients
Federico Bardazzi, Laura Bigi, Anna Campanati, et al.
Expert Opinion on Biological Therapy
|
January 19, 2022
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study
Marco Galluzzo, Marina Talamonti, Laura Atzori, et al.
Italian Journal of Dermatology and Venereology
|
July 25, 2025
Ethical and professional use of Social Media: Consensus of Italian Dermatologists active on social media
Lidia Sacchelli, Marta Fusano, Laura Colli, et al.
Expert Opinion on Biological Therapy
|
July 19, 2021
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy
Arianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini, et al.
Psoriasis (Auckland, N.Z.)
|
August 12, 2025
Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 years
Luca Mastorino, Paolo Dapavo, Martina Burlando, et al.
American Journal of Clinical Dermatology
|
April 15, 2025
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study
Ulrich Mrowietz, Crispin Meyer, Katja Großschädl, et al.
Page
of 8